These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 2821426

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The role of angiotensin II in the regulation of ACTH secretion.
    Ganong WF, Murakami K.
    Ann N Y Acad Sci; 1987; 512():176-86. PubMed ID: 2831773
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of central and peripheral angiotensin blockade in hypertensive rats.
    Mann JF, Phillips MI, Dietz R, Haebara H, Ganten D.
    Am J Physiol; 1978 May; 234(5):H629-37. PubMed ID: 645931
    [Abstract] [Full Text] [Related]

  • 6. [Sar,Ala]angiotensin II in cerebrospinal fluid blocks the binding of blood-borne [125I]angiotensin II to the circumventricular organs.
    Van Houten M, Mangiapane ML, Reid IA, Ganong WF.
    Neuroscience; 1983 Dec; 10(4):1421-6. PubMed ID: 6320051
    [Abstract] [Full Text] [Related]

  • 7. Will chronic intracerebroventricular saralasin infusion produce selective blockade of brain angiotensin II receptors in the rat?
    Bruner CA, Weaver JM, Fink GD.
    J Pharmacol Exp Ther; 1983 Jul; 226(1):13-8. PubMed ID: 6306220
    [Abstract] [Full Text] [Related]

  • 8. Angiotensin II increases the corticotropin-releasing factor messenger ribonucleic acid level in the rat hypothalamus.
    Sumitomo T, Suda T, Nakano Y, Tozawa F, Yamada M, Demura H.
    Endocrinology; 1991 May; 128(5):2248-52. PubMed ID: 1850346
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of catecholamine-depleting agents and receptor blockers on basal and angiotensin II- or norepinephrine-stimulated luteinizing hormone release in female rats.
    Steele MK, Ganong WF.
    Endocrinology; 1986 Dec; 119(6):2728-36. PubMed ID: 3023020
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Angiotensin II and adrenocorticotropin release: mediation by endogenous corticotropin-releasing factor.
    Spinedi E, Rodriguez G.
    Endocrinology; 1986 Sep; 119(3):1397-402. PubMed ID: 3015575
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Correlation between the stress-induced transient increase in corticotropin-releasing hormone content of the median eminence of the hypothalamus and adrenocorticotropic hormone secretion.
    Murakami K, Akana S, Dallman MF, Ganong WF.
    Neuroendocrinology; 1989 Mar; 49(3):233-41. PubMed ID: 2541356
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. cAMP-dependent ACTH secretagogues facilitate corticotropin releasing activity of angiotensin II on rat anterior pituitary cells in vitro.
    Schoenenberg P, Gaillard RC, Kehrer P, Muller AF.
    Acta Endocrinol (Copenh); 1987 Jan; 114(1):118-23. PubMed ID: 3028024
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Angiotensin II increases ACTH release in the absence of endogenous arginine-vasopressin.
    Spinedi E, Negro-Vilar A.
    Life Sci; 1984 Feb 20; 34(8):721-9. PubMed ID: 6321871
    [Abstract] [Full Text] [Related]

  • 20. Intracerebroventricular and systemic saralasin used to investigate angiotensin-elicited activation of the pituitary-adrenocortical axis in the goat.
    Junkergård J, Jónasson H.
    Acta Physiol Scand; 1988 Oct 20; 134(2):271-5. PubMed ID: 3227946
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.